Are there true and false classifications in noninvasive liver disease assessment for metabolic dysfunction-associated steatotic liver disease?
HW, et al. Histological severity and hepatic outcomes in patients with metabolic dysfunction-associated steatotic liver disease and discrepant FIB-4 and liver stiffness measurement. Clin Mol Hepatol 2026;32:289-304